New Issue: Natixis prices $1.15 million 13.75% reverse convertibles linked to Vertex for Eksportfinans

By Angela McDaniels

Seattle, May 3 - Natixis Securities North America Inc. priced a $1.15 million issue of 13.75% reverse convertible notes due May 7, 2008 linked to Vertex Pharmaceuticals Inc. for issuer Eksportfinans ASA, according to an FWP filing with the Securities and Exchange Commission.

Interest is payable quarterly.

The payout at maturity will be par unless Vertex stock falls below its knock-in price - 80% of the initial share price - during the life of the notes and finishes below its initial share price, in which case the payout will be a number of Vertex shares equal to $1,000 divided by its initial share price.

Issuer:	Eksportfinans ASA
Issue:	Reverse convertible notes
Underlying stock:	Vertex Pharmaceuticals Inc.
Amount:	$1.15 million
Maturity:	May 7, 2008
Coupon:	13.75%, payable quarterly
Price:	98
Payout at maturity:	If Vertex stock falls below its knock-in price during the life of the notes and finishes below its initial share price, 32.3729 Vertex shares; otherwise, par
Initial share price:	$30.89
Knock-in price:	$16.9895, 55% of initial share price
Pricing date:	May 3
Settlement date:	May 7
Agent:	Natixis Securities North America Inc.
Agent fees:	2%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.